Macarena Torrego-Ellacuría (Macarena Torrego Ellacuría, Macarena Torrego-Ellacuria)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 12

Top Topics

Bariatric Surgery

Respiratory Syndrome Coronavirus

Ejection Fraction

Top Venues

Journal of clinical medicine

International journal of environmental research and public health

This page only lists publications with an associated author ORCID identifier.

Publications

Macarena Torrego-Ellacuría, Ana Barabash, Pilar Matía, Andrés Sánchez-Pernaute, Antonio J Torres, Alfonso Luis Calle-Pascual, Miguel Ángel Rubio-Herrera
Combined Effect of Genetic Variants on Long-Term Weight Response after Bariatric Surgery. Journal of clinical medicine 12 (13) (2023)
Leire Bastida, Gloria Cea, Ana Moya, Alba M Gallego Montejo, Eugenio Gaeta, Sara Sillaurren, Paulo Barbosa, Sabrina Souto, Eujessika Rodrigues, Macarena Torrego-Ellacuría, Andreas K Triantafyllidis, Anastasios Alexiadis, Konstantinos Votis, Dimitrios Tzovaras, Cleilton Rocha, Lucas Alves, Pedro Malo, Marcio Mateus, José Fernando Rodrigues Ferreira Neto, María Teresa Arredondo Waldmeyer
Promoting Obesity Prevention and Healthy Habits in Childhood: The OCARIoT Experience. IEEE journal of translational engineering in health and medicine 11 (2023)
Javier David Benitez Fuentes, Alicia de Luna Aguilar, Alejandro Francisco Jimenez Ortega, Paloma Flores Navarro, Jorge Bartolomé Arcilla, Elvira Baos Muñoz, Alberto Delgado-Iribarren, Sara Gil Useros, Ignacio Martinez Capella, Laura Llorente Sanz, Macarena Torrego-Ellacuría, Pedro Pérez Segura
Adverse drug reactions to the three doses of the severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) mRNA-1273 vaccine in a cohort of cancer patients under active treatment of a tertiary hospital in Madrid, Spain. F1000Research 11 (2022)
Macarena Torrego-Ellacuría, Ana Barabash, Pilar Matía, Andrés Sánchez-Pernaute, Antonio J Torres, Alfonso Luis Calle-Pascual, Miguel Ángel Rubio-Herrera
Influence of CLOCK Gene Variants on Weight Response after Bariatric Surgery. Nutrients 14 (17) (2022)
Javier David Benitez Fuentes, Alicia de Luna Aguilar, Alejandro Francisco Jimenez Ortega, Paloma Flores Navarro, Jorge Bartolomé Arcilla, Elvira Baos Muñoz, Alberto Delgado-Iribarren, Sara Gil Useros, Ignacio Martinez Capella, Laura Llorente Sanz, Macarena Torrego-Ellacuría, Pedro Pérez Segura
Adverse drug reactions to the three doses of the severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) mRNA-1273 vaccine in a cohort of cancer patients under active treatment of a tertiary hospital in Madrid, Spain. F1000Research 11 (2022)
Javier David Benitez Fuentes, Alicia de Luna Aguilar, Alejandro Francisco Jimenez Ortega, Paloma Flores Navarro, Jorge Bartolomé Arcilla, Elvira Baos Muñoz, Alberto Delgado-Iribarren, Sara Gil Useros, Ignacio Martinez Capella, Laura Llorente Sanz, Macarena Torrego-Ellacuría, Pedro Pérez Segura
Adverse drug reactions to the three doses of the severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) mRNA-1273 vaccine in a cohort of cancer patients under active treatment of a tertiary hospital in Madrid, Spain. F1000Research 11 (2022)
Javier David Benitez Fuentes, Alicia de Luna Aguilar, Alejandro Francisco Jimenez Ortega, Paloma Flores Navarro, Jorge Bartolomé Arcilla, Elvira Baos Muñoz, Alberto Delgado-Iribarren, Sara Gil Useros, Ignacio Martinez Capella, Laura Llorente Sanz, Macarena Torrego-Ellacuría, Pedro Pérez Segura
Adverse drug reactions to the three doses of the severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) mRNA-1273 vaccine in a cohort of cancer patients under active treatment of a tertiary hospital in Madrid, Spain. F1000Research 11 (2022)
Javier David Benitez Fuentes, Alicia de Luna Aguilar, Alejandro Francisco Jimenez Ortega, Paloma Flores Navarro, Jorge Bartolomé Arcilla, Elvira Baos Muñoz, Alberto Delgado-Iribarren, Sara Gil Useros, Ignacio Martinez Capella, Laura Llorente Sanz, Macarena Torrego-Ellacuría, Pedro Pérez Segura
Adverse drug reactions to the three doses of the severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) mRNA-1273 vaccine in a cohort of cancer patients under active treatment of a tertiary hospital in Madrid, Spain. F1000Research 11 (2022)
Javier David Benitez Fuentes, Alicia de Luna Aguilar, Alejandro Francisco Jimenez Ortega, Paloma Flores Navarro, Jorge Bartolomé Arcilla, Elvira Baos Muñoz, Alberto Delgado-Iribarren, Sara Gil Useros, Ignacio Martinez Capella, Laura Llorente Sanz, Macarena Torrego-Ellacuría, Pedro Pérez Segura
Adverse drug reactions to the three doses of the severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) mRNA-1273 vaccine in a cohort of cancer patients under active treatment of a tertiary hospital in Madrid, Spain. F1000Research 11 (2022)
Javier David Benitez Fuentes, Alicia de Luna Aguilar, Alejandro Francisco Jimenez Ortega, Paloma Flores Navarro, Jorge Bartolomé Arcilla, Elvira Baos Muñoz, Alberto Delgado-Iribarren, Sara Gil Useros, Ignacio Martinez Capella, Laura Llorente Sanz, Macarena Torrego-Ellacuría, Pedro Pérez Segura
Adverse drug reactions to the three doses of the severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) mRNA-1273 vaccine in a cohort of cancer patients under active treatment of a tertiary hospital in Madrid, Spain. F1000Research 11 (2022)
Javier David Benitez Fuentes, Alicia de Luna Aguilar, Alejandro Francisco Jimenez Ortega, Paloma Flores Navarro, Jorge Bartolomé Arcilla, Elvira Baos Muñoz, Alberto Delgado-Iribarren, Sara Gil Useros, Ignacio Martinez Capella, Laura Llorente Sanz, Macarena Torrego-Ellacuría, Pedro Pérez Segura
Adverse drug reactions to the three doses of the severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) mRNA-1273 vaccine in a cohort of cancer patients under active treatment of a tertiary hospital in Madrid, Spain. F1000Research 11 (2022)
Eugenio Francisco Sánchez-Úbeda, Pedro Sánchez-Martín, Macarena Torrego-Ellacuría, Ángel Del Rey-Mejías, Manuel F Morales-Contreras, José-Luis Puerta
Flexibility and Bed Margins of the Community of Madrid's Hospitals during the First Wave of the SARS-CoV-2 Pandemic. International journal of environmental research and public health 18 (7) (2021)